A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from Africa.
<h4>Background</h4>Low dose radiation therapy (LDRT) has been used for non-malignant conditions since early 1900s based on the ability of single fractions between 50-150 cGy to inhibit cellular proliferation. Given scarcity of resources, poor access to vaccines and medical therapies with...
Main Authors: | Mansoor Saleh, Karishma Sharma, Jasmit Shah, Farrok Karsan, Angela Waweru, Martin Musumbi, Reena Shah, Shahin Sayed, Innocent Abayo, Noureen Karimi, Stacey Gondi, Sehrish Rupani, Grace Kirathe, Heldah Amariati |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0270594 |
Similar Items
-
Regulatory approval of clinical trials: is it time to reinvent the wheel?
by: Mansoor Saleh, et al.
Published: (2024-01-01) -
Mental health and quality of life following breast cancer diagnosis in patients seen at a tertiary care hospital in Nairobi, Kenya: A qualitative study
by: Divya Annamalai, et al.
Published: (2024-01-01) -
A New Look at the LDRT treatment for COVID-19 Associated Pneumonia: The Issues of Antiviral Resistance and Virus Spread-Ability
by: J J Bevelacqua, et al.
Published: (2020-10-01) -
The burden and characteristics of HIV-infected COVID-19 patients at a tertiary care hospital in sub-Saharan Africa-A retrospective cohort study.
by: Alok Iyer, et al.
Published: (2022-01-01) -
Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood – Interim Analysis of the IMMO-LDRT01 Trial
by: Anna-Jasmina Donaubauer, et al.
Published: (2021-10-01)